Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | IFNGR1 |
Ellen McDonagh gene: IFNGR1 was added gene: IFNGR1 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: IFNGR1 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for gene: IFNGR1 were set to 8960473; 8960475; 9389728; 9497247 Phenotypes for gene: IFNGR1 were set to Immunodeficiency 27A, (AR) 209950; Susceptibility to mycobacteria and Salmonella; Mycobacteriosis; Defects with susceptibility to mycobacterial infection (MSMD); Defects in Intrinsic and Innate Immunity; Immunodeficiency 27B, (AD) 615978 |